Bioneer Corporation (KOSDAQ:064550)

Market Cap	262.23B -33.4%
Revenue (ttm)	330.11B +12.3%
Net Income	-2.81B
EPS	-109.00
Shares Out	25.81M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	55,317
Average Volume	71,575
Open	10,220
Previous Close	10,160
Day's Range	10,220 - 10,440
52-Week Range	9,900 - 17,950
Beta	0.22
RSI	39.95
Earnings Date	Apr 1, 2026

About Bioneer

Bioneer Corporation operates as a biotechnology company in South Korea, the Americas, Europe, Asia, Africa, and internationally. The company offers PCR and RT-PCR, real-time PCR, RNAi, chemicals, plastic consumables, and buffer and solutions; and sample preparation, protein synthesis and purification, gene cloning, fluorescence dye and quencher, electrophoresis, genome-wide function, and magnetic separation services, as well as instruments for conventional PCR, real-time PCR, sample preparation, protein synthesis, centrifuge and vortex mixer, a...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1992
• Employees: 367
• Stock Exchange: KOSDAQ
• Ticker Symbol: 064550

Financial Performance

In 2025, Bioneer's revenue was 330.11 billion, an increase of 12.29% compared to the previous year's 293.98 billion. Losses were -2.81 billion, -86.33% less than in 2024.